Abstract
Many drugs are extensively but reversibly bound to plasma proteins (Meyer and Guttman, 1968). Albumin is particularly important in this regard since it binds a variety of substances of diverse structure and activity. In addition to drugs, various naturally occurring compounds such as bilirubin, thyroxine, fatty acids and certain steroids bind to albumin. The number of binding sites on albumin which have a relatively high affinity for drugs and hormones is limited and, under certain conditions, compounds may compete for such sites (Brodie, 1965). The rate of metabolism and excretion as well as the magnitude of the pharmacologic response is dependent, in part, upon the concentration of unbound drug. Thus, marked changes in pharmacologic activity and even toxicity may be observed when one compound is displaced by another from albumin (Brodie, 1966; Solomon, 1968). Such is particularly the case when the displaced compound is metabolized and/or excreted slowly. This review is concerned with the interaction between drugs and certain naturally occurring compounds relative to binding on plasma proteins.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Austen, F.K., Rubint, M.E., Meroney, W.H., Wolff, J.: Salicylates and thyroid function. I. Depression of thyroid function. J. clin. Invest. 37, 1131–1143 (1958).
Beisel, W.R., Diraimondo, V.C., Forsham, P.H.: Cortisol transport and disappearance. Ann. intern. Med. 60, 641–652 (1964).
Brodie, B. B.: Displacement of one drug by another from carrier or receptor sites. Proc. roy. Soc. Med. 58, 946–955 (1965).
Brodie, B.B. Pharmacological and clinical implications of drug transport. In: P. Desgrez, and P.M. Detraverse: Transport function of plasma proteins. Amsterdam-London-New York: Elsevier 1966.
Daughaday, W.H.: Steroid protein interactions. Physiol. Rev. 39, 885–902 (1959).
Demoor, P., Deckx, R., Steeno, O.: Influence of various steroids on the specific binding of cortisol. J. Endocr. 27, 355–356 (1963).
Desgrez, P.: Role of plasma proteins in corticosteroid transfer: Transcortin or C.B.G. In: P. Desgrez, and P.M. Detraverse: Transport function of plasma proteins. Amsterdam- London-New York: Elsevier 1966.
Dole, V.P.: A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J. clin. Invest. 35, 150–154 (1956).
Fredrickson, D.S., Gordon, R.S., JR.: Transport of fatty acids. Physiol. Rev. 38, 585–630 (1958).
Goodman, D. S.: The interaction of human serum albumin with long-chain fatty acid anions. J. Amer. Chem. Soc. 80, 3892–3898 (1958).
Johnson, L., Sarmiento, F., Blanc, W.A., Day, R.: Kernicterus in rats with an inherited deficiency of glucuronyl transferase. J. Dis. Child. 97, 591–608 (1959).
Josephson, B., Furst, P.: Sulfonamides competing with bilirubin for conjugation to albumin. Scand. J. clin. Lab. Invest. 18, 51–63 (1966).
Lathe, G.H., Lord, P., Toothill, C.: Bilirubin transport by plasma protein. In: P. Desgrez, and P.M. Detraverse: Transport function of plasma proteins. Amsterdam-London- New York: Elsevier 1966.
Lukas, D. S., Demartino, A. G.: Binding of digitoxin and some related cardinolides to human plasma proteins. J. clin. Invest. 48, 1041–1053 (1969).
Maickel, R.P., Bush, M.T., Jondorf, W.R., Miller, F.P., Gillette, J.R.: Factors influencing the metabolism and distribution of corticosterone-l,2-3H in the rat. Molec. Pharmacol. 2, 491 — 498 (1966).
Martin, N. H.: Preparation and properties of serum and plasma proteins. XXI. Interactions with bilirubin. J. Amer. chem. Soc. 71, 1230–1232 (1949).
Meyer, M.C., Guttman, D.E.: The binding of drugs by plasma proteins. J. pharm. Sci. 57, 895–918 (1968).
Odell, G. B.: Studies in kernicterus. I. The protein binding of bilirubin. J. clin. Invest. 38, 823–833 (1959).
Odell, G. B.: The distribution of bilirubin between albumin and mitochondria. J. Pediat. 68, 164–180 (1966).
Oppenheimer, J.H., Fisher, L.V., Nelson, K.M., Jailer, J.W.: Depression of the serum protein-bound iodine level by diphenylhydantoin. J. clin. Endocr. 21, 252–262 (1961).
Oppenheimer, J.H., Tavernetti, R. R.: Displacement of thyroxine from human thyroxine-binding globulin by analogues of hydantoin. Steric aspects of the thyroxine-binding site. J. clin. Invest. 41, 2213–2220 (1962).
Ostrow, J.D., Schmid, R.: The protein-binding of C14-bilirubin in human and murine serum. J. clin. Invest. 42, 1286–1299 (1963).
Peets, E.A., Staub, M., Symchowicz, S.: Plasma binding of betamethasone-3H, dexamethasone-3H, and cortisol-14C — a comparative study. Biochem. Pharmacol. 18, 1655–1663 (1969).
Robbins, J., Rall, J.E.: Effects of triiodothyronine and other thyroxine analogues on thyroxine-binding in human serum. J. clin. Invest. 34, 1331–1336 (1955).
Salvatore, G., Andreoli, M., Roche, J.: Thyroid hormones-plasma protein interaction. In: P. Desgrez, and P.M. Detraverse: Transport function of plasma proteins. Amsterdam- London-New York: Elsevier 1966.
Sandberg, A.A., Rosenthal, H., Schneider, S.L., Slaunwhite, W.R., JR.: Protein-steroid interactions and their role in the transport and metabolism of steroids. In: G. Pincus, T. Nakao and J.F. Tait: Steroid Dynamics. New York-London: Academic Press 1966.
Schellman, J. A., Lumry, R., Samuels, L.T.: The binding of uncharged molecules to proteins. II. Testosterone and bovine serum albumin. J. Amer. chem. Soc. 76, 2808–2813 (1954).
Schrogie, J. J., Solomon, H.M.: The anticoagulant response to bishydroxycoumarin: II. The effect of d-thyroxine, clofibrate, and norethandrolone. Clin. Pharmacol. Ther. 8, 70–77 (1967).
Silverman, W.A., Andersen, D.H., Blanc, W.A., Crozier, D.N.: A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 18, 614–625 (1956).
Solomon, H.M.: Displacement of drugs from plasma binding sites as a factor in drug toxicity. In: S.W. Goldstein: Development of safer and more effective drugs. Washington, D.C.: American Pharmaceutical Association 1968.
Solomon, H.M.: Schrogie, J.J.: The effect of various drugs on the binding of warfarin-14C to human albumin. Biochem. Pharmacol. 16, 1219–1226 (1967).
Solomon, H.M.: Williams, D.: The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids. Biochem. Pharmacol. 17, 143–151 (1968).
Spector, A.S., John, K., Fletscher, J.E.: Binding of long chain fatty acids to bovine serum albumin. J. Lipid Res. 10, 56–67 (1969).
Steiner, R.F., Roth, J., Robbins, J.: The binding of thyroxine by serum albumin as measured by fluorescence quenching. J. biol. Chem. 241, 560–567 (1966).
Stenlake, J.B., Williams, W.D., Davidson, A.G., Downie, W., Whaley, K.: The effect of anti-inflammatory drugs on the protein-binding of 11-hydroxysteroids in human plasma in vitro. J. Pharm. Pharmacol. 21, 451–459 (1969).
Sterling, K.: Molecular structure of thyroxine in relation to its binding by human serum albumin. J. clin. Invest. 43, 1721–1729 (1964).
Surks, M.I., Oppenheimer, J.H.: Effect of penicillin on thyroxine-binding by plasma proteins. Endocrinology 72, 567–573 (1963).
Takemura, Y., Yamada, T., Shichijo, K.: Effects of novobiocin on pituitary-thyroid axis in the rat and its mechanism. Metabolism 15, 566–576 (1966).
Thorp, J.M.: The influence of plasma proteins on the action of drugs. In: T.B. Binns: Absorption and distribution of drugs. Baltimore: Williams and Wilkins Co. 1964.
Winter, C.A., Risley, E.A., Silber, R.H.: Antiinflammatory activity of indomethacin and plasma corticosterone in rats. J. Pharmacol, exp. Ther. 162, 196–201 (1968).
Wolff, J., Rubin, L., Chaikoff, I.L.: The influence of 2,4-dinitrophenol on plasma protein- bound iodine. J. Pharmacol, exp. Ther. 98, 45–48 (1950).
Wolff, J., Rubin, L., Chaikoff, I.L., Standaert, M.E., Rall, J.E.: Thyroxine displacement from serum proteins and depression of serum protein-bound iodine by certain drugs. J. clin. Invest. 40, 1373–1379 (1961).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1971 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Solomon, H.M. (1971). Competition between Drugs and Normal Substrates for Plasma and Tissue Binding Sites. In: Brodie, B.B., Gillette, J.R., Ackerman, H.S. (eds) Concepts in Biochemical Pharmacology. Handbuch der experimentellen Pharmakologie/Handbook of Experimental Pharmacology, vol 28 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65052-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-65052-9_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65054-3
Online ISBN: 978-3-642-65052-9
eBook Packages: Springer Book Archive